As it is not an approved drug for the OA indication it does not surprise me at all. As investors in the company we just think it has such amazing potential that more people should know about, especially those in the medical field. The reality is 95% haven’t a clue about it.
It is at the point of the granting of the IND and commencement of phase 3 trials that this will slowly start to change. As we get initial readings from the phase 3 I could see us on the news etc.
Trial PAR008 is on ANZCTR, page-34
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.010(4.17%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 24.5¢ | $46.25K | 182.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 65697 | 4 |
View Market Depth
| Last trade - 16.10pm 16/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |